Literature DB >> 29678950

Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning.

Jeremiah D Heredia1, Jihye Park1, Riley J Brubaker1, Steven K Szymanski1, Kevin S Gill1, Erik Procko2.   

Abstract

Chemokine receptors CXCR4 and CCR5 regulate WBC trafficking and are engaged by the HIV-1 envelope glycoprotein gp120 during infection. We combine a selection of human CXCR4 and CCR5 libraries comprising nearly all of ∼7000 single amino acid substitutions with deep sequencing to define sequence-activity landscapes for surface expression and ligand interactions. After consideration of sequence constraints for surface expression, known interaction sites with HIV-1-blocking Abs were appropriately identified as conserved residues following library sorting for Ab binding, validating the use of deep mutational scanning to map functional interaction sites in G protein-coupled receptors. Chemokine CXCL12 was found to interact with residues extending asymmetrically into the CXCR4 ligand-binding cavity, similar to the binding surface of CXCR4 recognized by an antagonistic viral chemokine previously observed crystallographically. CXCR4 mutations distal from the chemokine binding site were identified that enhance chemokine recognition. This included disruptive mutations in the G protein-coupling site that diminished calcium mobilization, as well as conservative mutations to a membrane-exposed site (CXCR4 residues H792.45 and W1614.50) that increased ligand binding without loss of signaling. Compared with CXCR4-CXCL12 interactions, CCR5 residues conserved for gp120 (HIV-1 BaL strain) interactions map to a more expansive surface, mimicking how the cognate chemokine CCL5 makes contacts across the entire CCR5 binding cavity. Acidic substitutions in the CCR5 N terminus and extracellular loops enhanced gp120 binding. This study demonstrates how comprehensive mutational scanning can define functional interaction sites on receptors, and novel mutations that enhance receptor activities can be found simultaneously.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29678950      PMCID: PMC5964024          DOI: 10.4049/jimmunol.1800343

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  83 in total

1.  Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.

Authors:  T R Fouts; R Tuskan; K Godfrey; M Reitz; D Hone; G K Lewis; A L DeVico
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.

Authors:  Yi Zheng; Gye Won Han; Ruben Abagyan; Beili Wu; Raymond C Stevens; Vadim Cherezov; Irina Kufareva; Tracy M Handel
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

3.  Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

Authors:  M Farzan; T Mirzabekov; P Kolchinsky; R Wyatt; M Cayabyab; N P Gerard; C Gerard; J Sodroski; H Choe
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

4.  The spatial architecture of protein function and adaptation.

Authors:  Richard N McLaughlin; Frank J Poelwijk; Arjun Raman; Walraj S Gosal; Rama Ranganathan
Journal:  Nature       Date:  2012-10-07       Impact factor: 49.962

Review 5.  HIV-1 envelope glycoprotein structure.

Authors:  Alan Merk; Sriram Subramaniam
Journal:  Curr Opin Struct Biol       Date:  2013-04-18       Impact factor: 6.809

6.  Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.

Authors:  Melanie P Wescott; Irina Kufareva; Cheryl Paes; Jason R Goodman; Yana Thaker; Bridget A Puffer; Eli Berdougo; Joseph B Rucker; Tracy M Handel; Benjamin J Doranz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-19       Impact factor: 11.205

7.  Structural and molecular interactions of CCR5 inhibitors with CCR5.

Authors:  Kenji Maeda; Debananda Das; Hiromi Ogata-Aoki; Hirotomo Nakata; Toshikazu Miyakawa; Yasushi Tojo; Rachael Norman; Yoshikazu Takaoka; Jianping Ding; Gail F Arnold; Eddy Arnold; Hiroaki Mitsuya
Journal:  J Biol Chem       Date:  2006-02-13       Impact factor: 5.157

8.  A rapid screening and production method using a novel mammalian cell display to isolate human monoclonal antibodies.

Authors:  Kosuke Tomimatsu; Shin-ei Matsumoto; Hayato Tanaka; Makiko Yamashita; Hidekazu Nakanishi; Kiichiro Teruya; Saiko Kazuno; Tomoya Kinjo; Takeki Hamasaki; Ken-ichi Kusumoto; Shigeru Kabayama; Yoshinori Katakura; Sanetaka Shirahata
Journal:  Biochem Biophys Res Commun       Date:  2013-10-16       Impact factor: 3.575

9.  Activation and allosteric modulation of a muscarinic acetylcholine receptor.

Authors:  Andrew C Kruse; Aaron M Ring; Aashish Manglik; Jianxin Hu; Kelly Hu; Katrin Eitel; Harald Hübner; Els Pardon; Celine Valant; Patrick M Sexton; Arthur Christopoulos; Christian C Felder; Peter Gmeiner; Jan Steyaert; William I Weis; K Christopher Garcia; Jürgen Wess; Brian K Kobilka
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

10.  Dynamic Cholesterol-Conditioned Dimerization of the G Protein Coupled Chemokine Receptor Type 4.

Authors:  Kristyna Pluhackova; Stefan Gahbauer; Franziska Kranz; Tsjerk A Wassenaar; Rainer A Böckmann
Journal:  PLoS Comput Biol       Date:  2016-11-03       Impact factor: 4.475

View more
  17 in total

1.  Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.

Authors:  Jeremiah D Heredia; Jihye Park; Hannah Choi; Kevin S Gill; Erik Procko
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

2.  Structural architecture of a dimeric class C GPCR based on co-trafficking of sweet taste receptor subunits.

Authors:  Jihye Park; Balaji Selvam; Keisuke Sanematsu; Noriatsu Shigemura; Diwakar Shukla; Erik Procko
Journal:  J Biol Chem       Date:  2019-02-05       Impact factor: 5.157

3.  Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.

Authors:  Bryan S Stephens; Tony Ngo; Irina Kufareva; Tracy M Handel
Journal:  Sci Signal       Date:  2020-07-14       Impact factor: 8.192

Review 4.  Cytokines and chemokines involved in the defense reaction against HIV-1 and hepatitis B virus: isn't it time to use a standardized nomenclature of the involved mediators?

Authors:  Lutz G Gürtler
Journal:  Virus Genes       Date:  2019-12-17       Impact factor: 2.332

Review 5.  Understanding molecular mechanisms in cell signaling through natural and artificial sequence variation.

Authors:  Neel H Shah; John Kuriyan
Journal:  Nat Struct Mol Biol       Date:  2018-12-31       Impact factor: 15.369

6.  High-Throughput Discovery and Characterization of Human Transcriptional Effectors.

Authors:  Josh Tycko; Nicole DelRosso; Gaelen T Hess; Abhimanyu Banerjee; Aditya Mukund; Mike V Van; Braeden K Ego; David Yao; Kaitlyn Spees; Peter Suzuki; Georgi K Marinov; Anshul Kundaje; Michael C Bassik; Lacramioara Bintu
Journal:  Cell       Date:  2020-12-15       Impact factor: 66.850

7.  Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity.

Authors:  Tony Ngo; Bryan S Stephens; Martin Gustavsson; Lauren G Holden; Ruben Abagyan; Tracy M Handel; Irina Kufareva
Journal:  PLoS Biol       Date:  2020-04-09       Impact factor: 8.029

Review 8.  Predicting Drug Resistance Using Deep Mutational Scanning.

Authors:  Gur Pines; Reilly G Fankhauser; Carrie A Eckert
Journal:  Molecules       Date:  2020-05-11       Impact factor: 4.411

9.  Bridging non-overlapping reads illuminates high-order epistasis between distal protein sites in a GPCR.

Authors:  Justin I Yoo; Patrick S Daugherty; Michelle A O'Malley
Journal:  Nat Commun       Date:  2020-02-04       Impact factor: 14.919

10.  The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2.

Authors:  Erik Procko
Journal:  bioRxiv       Date:  2020-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.